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Background and Objective: HBHA (heparin-binding hemagglutinin) is a surface adhesin that mediate in binding to host cells by its own unique, carboxyl-terminal region. This
methylated region has specific motif that rich of lysine-, alanine-, and proline amino acids. More recently, has been shown that HBHA has potential activity in stimulating immune
responses and is a promising new candidate for diagnostic and protective antigen against tuberculosis. Interferon-gamma release assay test (IGRAs) is a new method to identifying latent
tuberculosis and in compared to old method, tuberculin skin test (TST), has several advantages. Therefore in this study recombinant heparin-binding haemagglutinin antigen as new
antigen in IGRAs test was produced.
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Materials and Methods: In present work hbha and mtb32C genes were isolated from Mycobacterium tuberculosis H37Rv genome by PCR. PCR products and pet21+ vector were digested
with specific restriction enzymes and then submitted to ligation procedure. E. coli BL21-CodonPlus (DE3) competent cells were transformed with recombinant Mtb32C-HBHA –pet21+
vector. Expression of recombinant protein (Mtb32C-HBHA) was confirmed with SDS-PAGE and Western blot methods.
Results: Detection of about 500 bp gene in Colony-PCR method and sequencing of recombinant pet-Mtb32C-HBHA vector all confirmed the accuracy of cloning procedure. Also
presence of a 36 KDa protein band was confirmed with Western blotting method(Fig.1,2,3).
Conclusion:
In this study, expression of Mtb32C-HBHA protein in prokaryotic system successfully was done and production of new recombinant protein confirmed by western blot technique and
anti His tag antibodies. Other studies are needed to evaluate efficacy of recombinant Mtb32C-HBHA protein in diagnosis of latent tuberculosis.
Fig.1: Colony-PCR results that show amplification of
about 1000bp of mtb32C-HBHA fragment of
recombinant mtb32C-hbha – pet21+ using mtb32C-
HBHA specific primers (lane 2, 3); lane M: 100bp
DNA size marker
Figure 2: Detection of mtb32C-hbha mRNA in transformed and non-transformed. E. coli BL21 (DE3)
CodonPlus cells by RT-PCR analysis. By using specific primers designated for mtb32C-hbha genes
showed negative results in non-transformed cells (lane2) and a band with a size of 1000bp in
transformed cells with recombinant vector (lane 3). Lane 1: 1kb DNA size marker
Fig 3: Western blot analysis that confirm presence of recombinant protein (36kDa protein
band) in transformed bacteria (lane 1) but not in non transformed bacteria (lane 2); M:
protein size marker
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